Second cancer incidence in CLL patients receiving BTK inhibitors
David A. Bond, Ying Huang, James L. Fisher, Amy S. Ruppert, Dwight H. Owen, Erin M. Bertino, Kerry A. Rogers, Seema A. Bhat, Michael R. Grever, Samantha Jaglowski, Kami J. Maddocks, John C. Byrd, Jennifer A. Woyach
Topics & Concepts
Chronic lymphocytic leukemiaIbrutinibMedicineInternal medicineCumulative incidenceIncidence (geometry)PopulationCancerOncologyGastroenterologyLeukemiaCohortOpticsPhysicsEnvironmental healthChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentGastrointestinal Tumor Research and Treatment